Related Experiment Video
Updated: Nov 1, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
ATMIN Suppresses Metastasis by Altering the WNT-Signaling Pathway via PARP1 in MSI-High Colorectal Cancer
Yue-Ju Li1,2, Cheng-Ning Yang1, Mark Yen-Ping Kuo1
1Graduate Institute of Clinical Dentistry, School of Dentistry, National Taiwan University, Taipei, Taiwan.
Background:
Constant DNA damage occurs in cells, and the cells are programmed to respond constitutively. This study explored the roles of ataxia-telangiectasia mutated interactor (ATMIN), one of the impaired pathways involving the DNA damage response (DDR) in mismatch repair-deficient [microsatellite instability (MSI)-high] colorectal carcinoma (CRC).
Methods:
Expression of ATMIN messenger RNA (mRNA) was detected in CRC specimens with microsatellite instability (MSI) characteristics. The effects of ectopic ATMIN expression and ATMIN knockdown on invasion abilities were evaluated in MSI-high cell lines, and liver metastasis ability was investigated in vivo. Protein-protein interactions were assessed by coimmunoprecipitation analyses in vitro.
Results:
Decreased ATMIN expression was positively correlated with advanced stage of disease (P < 0.05), lymph node metastases (P < 0.05), and deeper invasion (P < 0.05) in MSI-high tumors. Transient or stable ATMIN knockdown significantly increased cell motility. Moreover, in the high-throughput microarray and gene set enrichment analysis, ATMIN was shown to act on the Wnt-signaling pathway via PARP1. This cascade influences β-catenin/transcription factor 4 (TCF4) binding affinity in MSI-high tumors, and PARP1 inhibition significantly decreased the number of metastases from ATMIN knockdown cancer cells.
Conclusions:
The results not only indicated the critical role of ATMIN, but also shed new light on PARP1 inhibitors, providing a basis for further clinical trials of MSI-high CRC.
Insights
Ataxia-telangiectasia mutated interactor (ATMIN) plays a key role in colorectal cancer (CRC) progression. Lower ATMIN levels correlate with advanced disease, and targeting PARP1 may offer new therapeutic strategies for MSI-high CRC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DNA damage response (DDR) is crucial for cellular integrity.
- Mismatch repair-deficient (MSI-high) colorectal carcinoma (CRC) involves impaired DDR pathways.
- Ataxia-telangiectasia mutated interactor (ATMIN) is implicated in DDR pathways within MSI-high CRC.
Purpose of the Study:
- To investigate the role of ATMIN in MSI-high colorectal carcinoma.
- To explore the relationship between ATMIN expression and tumor progression.
- To elucidate the molecular mechanisms involving ATMIN in CRC metastasis.
Main Methods:
- ATMIN mRNA expression was quantified in CRC specimens.
- In vitro and in vivo assays assessed the impact of ATMIN modulation on cell invasion and metastasis.
- Coimmunoprecipitation identified protein-protein interactions.
- Microarray and gene set enrichment analysis revealed signaling pathway involvement.
Main Results:
- Reduced ATMIN expression correlated with advanced disease stage, lymph node metastasis, and deeper tumor invasion in MSI-high CRC.
- ATMIN knockdown enhanced cancer cell motility and invasion.
- ATMIN influences the Wnt signaling pathway via PARP1 and β-catenin/TCF4 binding.
- PARP1 inhibition reduced metastasis in ATMIN-knockdown cells.
Conclusions:
- ATMIN is a critical factor in MSI-high CRC progression.
- The study highlights a novel ATMIN-PARP1-Wnt signaling axis.
- Findings support further clinical trials of PARP1 inhibitors for MSI-high CRC.
Related Concept Videos
Abnormal Proliferation
Canonical Wnt Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

